Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05351229 · ClinicalTrials.gov registry record · Phase 4

Intrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery

A Phase 4 study of Pain, Postoperative, sponsored by Northwestern University.

Recruiting
Registry status
Phase 4
Development phase
90
Enrollment target
1
Study location

NCT05351229 is a Phase 4 study of Pain, Postoperative that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 90 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05351229, a Phase 4 study of Pain, Postoperative, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
Phase 4
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

VATS/RATS is widely used for diagnosis and treatment of intrathoracic conditions. Despite many benefits, postoperative pain continues to be intense after VATS/RATS. The optimal strategy for pain management has not been defined. In this randomized, placebo-controlled, double-blinded clinical investigation, investigators hypothesize that 5 mcg/kg intrathecal morphine will decrease postoperative analgesic consumption and reduce pain.

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG Morphine Sulfate

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-09-29
Est. Completion 2026-09-01
Phase Phase 4

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT05351229

The ClinicalTrials.gov registry entry for NCT05351229 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (67% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05351229 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05351229 about?

NCT05351229 is a clinical study titled "Intrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery". VATS/RATS is widely used for diagnosis and treatment of intrathoracic conditions. Despite many benefits, postoperative pain continues to be intense after VATS/RATS. The optimal strategy for pain management has not been defined. In this randomized, placebo-controlled, double-blinded clinical investig...

What is the current status of trial NCT05351229?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2023-09-29. Estimated completion is 2026-09-01.

What conditions does trial NCT05351229 study?

This clinical trial studies the following conditions: Pain, Postoperative.

What interventions are being tested in trial NCT05351229?

The interventions under investigation include: Placebo (OTHER), Morphine Sulfate (DRUG).

Who is sponsoring clinical trial NCT05351229?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05351229 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.